Our global life sciences company brings diagnostic testing & drug development together. Explore what we do.
GenoSure PRIme® is the first HIV resistance test to provide genotypic resistance information for all Department of Health and Human Services (DHHS)-preferred first-line options, including integrase inhibitors.
GenoSure PRIme is a comprehensive resistance test for four classes of HIV drugs, including protease inhibitors (PIs), nucleoside reverse transcriptase inhibitors (NRTIs), nonnucleoside reverse transcriptase inhibitors (NNRTIs), and integrase inhibitors (INIs).
Consider GenoSure PRIme for baseline HIV resistance and detection of transmitted resistance at initiation of therapy.1
Consider GenoSure PRIme when contemplating changes to your patient’s course of therapy because your patient has suboptimal virologic response or viral load rebound.1
For more information, contact Monogram client services at 800-777-0177.
*If the assay fails on the initial attempt, HIV-1 RNA quantitation will be performed. If the result is <500 copies/mL, the viral load will be reported and the client will be billed.